Immunogenicity and Safety of NVX-CoV2373 as a Homologous or Heterologous Booster: A Phase 3 Randomized Clinical Trial in Adults https://www.medrxiv.org/content/10.1101/2023.03.16.23287030
Immunogenicity and Safety of NVX-CoV2373 as a Homologous or Heterologous Booster: A Phase 3 Randomized Clinical Trial in Adults https://www.medrxiv.org/content/10.1101/2023.03.16.23287030